Stockscreener 앱 받기
13.25
13.91%
-2.14
시간 외 거래:
13.04
-0.21
-1.58%
전일 마감가:
$15.39
열려 있는:
$14.68
하루 거래량:
248.44K
Relative Volume:
0.08
시가총액:
$20.99M
수익:
$74,000
순이익/손실:
$-13.43M
주가수익비율:
-1.4096
EPS:
-9.4
순현금흐름:
$-10.54M
1주 성능:
+23.14%
1개월 성능:
+3,903%
6개월 성능:
+132.49%
1년 성능:
-49.19%
1일 변동 폭
$12.28
$15.03
1주일 범위
$12.28
$19.87
52주 변동 폭
$0.215
$39.84
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
명칭
Cyclacel Pharmaceuticals Inc
전화
908-517-7330
주소
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
CYCC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
13.25 | 24.38M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-04-27 | 재개 | ROTH Capital | Buy |
| 2018-09-07 | 개시 | Ladenburg Thalmann | Buy |
| 2015-10-16 | 개시 | H.C. Wainwright | Buy |
| 2010-02-04 | 개시 | Roth Capital | Buy |
| 2009-10-28 | 개시 | Merriman | Buy |
| 2008-08-12 | 개시 | Piper Jaffray | Buy |
| 2008-03-12 | 재확인 | Cantor Fitzgerald | Buy |
| 2008-03-12 | 재확인 | Collins Stewart | Buy |
| 2008-03-12 | 재확인 | Needham & Co | Buy |
| 2007-11-27 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-08-10 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-06-04 | 재확인 | Needham & Co | Buy |
| 2007-04-23 | 개시 | Lazard Capital | Buy |
| 2007-04-10 | 개시 | Cantor Fitzgerald | Buy |
모두보기
Cyclacel Pharmaceuticals Inc 주식(CYCC)의 최신 뉴스
What Technical Tools Say About Cyclacel Pharmaceuticals Inc. RecoveryFast Entry High Potential Stock Alerts Triggered - metal.it
How high can Cyclacel Pharmaceuticals Inc. stock goAI Trade Signal Forecast with Chart Logic - Newser
Custom strategy builders for tracking Cyclacel Pharmaceuticals Inc.Free Daily Momentum Screener With Alerts - Newser
Cyclacel Pharmaceuticals Inc. recovery potential after sell offWeekly Gain Forecast with Momentum Indicators - Newser
Full technical analysis of Cyclacel Pharmaceuticals Inc. stockProven Trading System with Consistent Gains - Newser
What the charts say about Cyclacel Pharmaceuticals Inc. todayConservative Asset Allocation Risk Analysis - Newser
Why Cyclacel Pharmaceuticals Inc. stock attracts strong analyst attentionReal-Time Entry Signals for Top Stocks - Newser
Is Cyclacel Pharmaceuticals Inc. Starting a New UptrendSector Based Breakout Stock Forecast Issued - metal.it
Cyclacel Pharmaceuticals Amends Series F Stock Limitations - TipRanks
What institutional investors are buying Cyclacel Pharmaceuticals Inc. stockMarket-leading growth rates - jammulinksnews.com
What are Cyclacel Pharmaceuticals Inc. company’s key revenue driversFree Consultation - jammulinksnews.com
What are the latest earnings results for Cyclacel Pharmaceuticals Inc.Achieve superior capital gains with smart trades - jammulinksnews.com
Using Python tools to backtest Cyclacel Pharmaceuticals Inc. strategiesAI Trading Forecast Based on Big Data - Newser
What is the risk reward ratio of investing in Cyclacel Pharmaceuticals Inc. stockUnlock daily market insights for better decisions - jammulinksnews.com
Does Cyclacel Pharmaceuticals Inc. stock perform well during market downturnsHigh-profit stock alerts - jammulinksnews.com
When is Cyclacel Pharmaceuticals Inc. stock expected to show significant growthInvest confidently with proven investment plans - jammulinksnews.com
What are analysts’ price targets for Cyclacel Pharmaceuticals Inc. in the next 12 monthsGet professional advice for market timing - jammulinksnews.com
Should I hold or sell Cyclacel Pharmaceuticals Inc. stock in 2025Track stocks with high upside potential easily - jammulinksnews.com
How strong is Cyclacel Pharmaceuticals Inc. company’s balance sheetSky-high profits - jammulinksnews.com
Is Cyclacel Pharmaceuticals Inc. stock overvalued or undervaluedDynamic investment growth - jammulinksnews.com
What makes Cyclacel Pharmaceuticals Inc. stock price move sharplyFree Access to Stock Community - Newser
Competitive Positioning of Cyclacel Pharmaceuticals Inc.: Is It Leading or LaggingCapital Safe Smart Trades - Newser
What analysts say about Cyclacel Pharmaceuticals Inc. stockSuperior investment outcomes - PrintWeekIndia
Is Cyclacel Pharmaceuticals Inc. a good long term investmentFree Capital Allocation Plans - PrintWeekIndia
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY - ADVFN Brasil
How Cyclacel Pharmaceuticals Inc. stock reacts to Fed policy changesFree Trading Psychology Coaching - jammulinksnews.com
What drives Cyclacel Pharmaceuticals Inc. stock priceExponential wealth increase - Autocar Professional
Is Cyclacel Pharmaceuticals Inc. stock overhyped or has real potentialDynamic investment opportunities - jammulinksnews.com
Cyclacel Pharmaceuticals Inc. Stock Analysis and ForecastFree Popular Stock Recommendations - Autocar Professional
(CYCCP) Technical Pivots with Risk Controls - news.stocktradersdaily.com
CYCC’s Financial Health: Exploring Cyclacel Pharmaceuticals Inc’s Debt-to-Equity Ratio of 1.79 - investchronicle.com
Cyclacel Plunges 11.09% on Revenue Guidance Cut - AInvest
Wall Street Zen Downgrades Cyclacel Pharmaceuticals (NASDAQ:CYCC) to Sell - Defense World
Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.28%
2.59%
자본화:
|
볼륨(24시간):